The global image-guided therapy systems market size was valued at USD 5.36 billion in 2025 and is projected to grow from USD 5.63 billion in 2026 to USD 8.39 billion by 2034 at a CAGR of 5.1% during the forecast period 2026-2034. Americas dominated the image-guided therapy systems market with a market share of 43.2% in 2025.
Image-guided therapy is a modern approach to the surgical interventions that enable the use of imaging platform to plan, perform, and evaluate the therapeutic interventions and surgical procedures. Image-guided therapy is a diagnostic technology that is extensively used in minimally invasive procedures. The image therapy systems market is majorly driven by the increasing preference of minimally invasive surgeries, technological advancements in medical imaging, and the growing burden of chronic diseases across the globe.
Download a Free Sample To learn more about this report,
Image-guided therapy is moving toward smarter, more connected, and less invasive procedures. A major trend is the integration of artificial intelligence with live imaging to help physicians visualize devices, improve navigation, and support faster decisions during complex interventions. Healthcare companies are also focusing on lowering radiation exposure while maintaining image quality. Connected platforms that combine imaging, patient data, and treatment planning are becoming more important in interventional cardiology and other specialties. At the same time, compact and flexible imaging systems are being developed to improve access around the patient and support more efficient procedure-room workflows.
The growing use of minimally invasive procedures is a key factor supporting demand for image-guided therapy systems. These technologies help clinicians navigate instruments and devices with greater visual control, which is valuable in complex procedures involving the heart, brain, blood vessels, and other sensitive areas. Advances in AI, 3D visualization, and real-time image processing are also improving procedural guidance and workflow efficiency. In addition, healthcare providers are seeking technologies that can support precision care while managing increasing procedure volumes and staff pressures. The FDA's expanding clearance of AI-enabled medical devices also reflects the rapid development of software-assisted imaging and clinical decision-support technologies.
High equipment costs and the need for specialized infrastructure can limit the adoption of advanced image-guided therapy systems, particularly in smaller hospitals and healthcare facilities with restricted budgets. These systems may also require trained professionals who can operate complex imaging and navigation technologies safely. Another concern is radiation exposure during procedures that use X-ray-based imaging, creating continued demand for dose-reduction technologies and strict safety practices. Integration with existing hospital systems can add further complexity when imaging, software, and medical devices come from different platforms. Regulatory requirements for AI-enabled medical technologies may also increase development and validation demands before new solutions can reach clinical use.
The expansion of AI-enabled procedural guidance creates significant opportunities for image-guided therapy providers. AI can help clinicians track devices, improve visualization, automate parts of image analysis, and support more consistent workflows. Structural heart procedures, interventional cardiology, oncology, and minimally invasive treatments are particularly promising areas for technology development. There is also an opportunity to build integrated platforms that connect imaging, treatment planning, navigation, and post-procedure assessment in a single workflow. As healthcare systems face rising imaging volumes and workforce pressures, technologies that improve efficiency without compromising clinical quality may gain greater adoption.
One of the main challenges is balancing advanced imaging performance with patient and staff safety. X-ray-based procedures require careful radiation management, while complex interventions demand reliable imaging and highly trained clinical teams. Another challenge is ensuring that AI-enabled tools work consistently across different patient anatomies, clinical settings, and imaging conditions. Hospitals must also manage cybersecurity, data integration, regulatory compliance, and interoperability when adopting connected systems. The rapid pace of innovation can create additional pressure for healthcare providers to upgrade equipment and train staff. These factors can make implementation more difficult, even when new technologies offer potential improvements in precision and workflow efficiency.
Request Customizationto receive a tailored report.
Computed Tomography (CT) Scanners held the highest share of the image-guided therapy systems market, accounting for 23.4%, with a market value of USD 1.25 billion and a CAGR of 6.92%. Their leading position is supported by their ability to provide detailed cross-sectional images that help physicians plan and guide complex procedures. CT-based guidance is widely used in areas such as oncology, neurosurgery, and interventional procedures. Continued improvements in image resolution, faster scanning, dose management, and integration with advanced treatment planning are supporting demand for CT systems in modern healthcare facilities.
Other product categories, including Ultrasound Systems, MRI, Endoscopes, X-ray Fluoroscopy, PET, and SPECT, also contribute to the expanding use of image-guided therapy. Ultrasound is valued for its real-time imaging and lack of ionizing radiation, while MRI provides detailed soft-tissue visualization. Endoscopes support minimally invasive procedures by allowing direct internal visualization. X-ray fluoroscopy remains important for real-time procedural guidance, whereas PET and SPECT are particularly useful for functional and molecular imaging. Together, these technologies are helping clinicians improve procedural precision and expand minimally invasive treatment options.
Oncology Surgery is the fastest-growing application segment, with a CAGR of 7.84% during the forecast period. The increasing use of image guidance in cancer treatment is driven by the need for greater precision when targeting tumors while protecting surrounding healthy tissue. Advanced imaging technologies help surgeons and interventional specialists locate lesions, plan treatment, and monitor procedures more effectively. The growing burden of cancer, combined with advances in minimally invasive oncology procedures and image-assisted tumor ablation, is creating stronger demand for sophisticated guidance systems. Improved imaging accuracy and real-time visualization are also supporting more personalized approaches to cancer care.
Other applications include Cardiac Surgery, Neurosurgery, Orthopedic Surgery, Urology, Gastroenterology, and various other specialized procedures. Cardiac applications benefit from accurate imaging during complex interventions, while neurosurgery relies on detailed visualization for procedures involving sensitive brain structures. Orthopedic applications use imaging to improve surgical planning and implant placement. In urology and gastroenterology, image-guided techniques support minimally invasive diagnosis and treatment. These applications are gaining wider acceptance as hospitals seek safer procedures, shorter recovery periods, better clinical outcomes, and more precise control during complex interventions.
Speak to an Analystto discuss market opportunities.
The Americas dominated the image-guided therapy systems market with a market share of 43.2% and a value of USD 2.32 billion. The region is expected to register a CAGR of 6.42%. Market development is supported by the broad adoption of advanced medical imaging technologies, established healthcare facilities, and growing demand for minimally invasive procedures. Hospitals and specialized treatment centers are increasingly integrating imaging systems with therapeutic platforms to improve procedural accuracy and patient outcomes. Continued clinical innovation and the modernization of diagnostic and surgical infrastructure further support the regional market.
The United States represents an important market for image-guided therapy systems due to its advanced hospital infrastructure and strong focus on technology-enabled medical procedures. Healthcare providers are adopting integrated imaging and therapy platforms for interventional cardiology, oncology, neurosurgery, orthopedics, and other complex clinical applications. The presence of established medical technology manufacturers also encourages product innovation and faster commercialization. Hospitals increasingly prioritize real-time visualization, procedural precision, and minimally invasive treatment approaches. Growing investments in hybrid operating rooms, robotic assistance, digital imaging, and clinical workflow integration are further strengthening the adoption of image-guided therapy systems across the country.
Canada’s image-guided therapy systems market is supported by the modernization of hospitals and the growing need for accurate, minimally invasive treatment methods. Healthcare institutions are using image-guided technologies to improve clinical decision-making and enable physicians to monitor procedures in real time. Demand is particularly supported by the treatment of cardiovascular conditions, cancer, neurological disorders, and musculoskeletal diseases. Public healthcare organizations are also focusing on improving access to sophisticated diagnostic and interventional technologies. Collaboration among hospitals, universities, research institutions, and medical device companies is encouraging clinical research and practical innovation, creating a favorable environment for the wider use of integrated therapy systems.
Brazil is an important Latin American market for image-guided therapy systems, supported by the expansion of private healthcare facilities and the gradual modernization of major hospitals. Medical centers are showing greater interest in minimally invasive therapies that can shorten recovery periods and improve procedural precision. Demand is developing across interventional radiology, cardiology, oncology, and orthopedic care. Leading urban hospitals are strengthening their imaging capabilities and adopting advanced systems for complex treatments. However, differences in healthcare access and purchasing capacity may affect adoption across locations. Medical training, infrastructure development, and partnerships with international technology providers are expected to support broader market penetration.
Asia Pacific is the fastest-growing region in the image-guided therapy systems market, with the highest CAGR of 8.21%. The region accounted for a market share of 22.6% and a value of USD 1.21 billion. Growth is supported by improving healthcare infrastructure, increasing awareness of minimally invasive procedures, and the adoption of modern imaging technologies. Hospitals are expanding their capabilities in interventional radiology, cardiology, oncology, and surgery. Rising healthcare requirements and continued investments in advanced treatment facilities are also encouraging demand. Local and international manufacturers are strengthening their presence to serve the region’s diverse clinical needs.
Japan has a well-developed healthcare system that supports the adoption of advanced image-guided therapy systems. Hospitals and specialized medical centers emphasize procedural accuracy, patient safety, and efficient treatment delivery, creating demand for integrated imaging and therapeutic solutions. The country’s aging population is also increasing the need for effective management of cardiovascular diseases, cancer, neurological conditions, and orthopedic disorders. Japanese healthcare providers have strong experience with advanced imaging equipment and minimally invasive clinical techniques. Research partnerships between medical institutions and technology companies further encourage product development. Demand is also supported by interest in robotics, digital workflows, high-resolution visualization, and precision-based treatment planning.
China is experiencing increasing adoption of image-guided therapy systems as hospitals expand their diagnostic, surgical, and interventional capabilities. The development of large medical centers and specialized treatment facilities is improving access to advanced imaging technologies. Healthcare providers are showing greater interest in minimally invasive procedures because they can support precise treatment, reduce damage to surrounding tissue, and improve patient recovery. Domestic manufacturers are strengthening their medical technology capabilities, while international companies are expanding through partnerships and distribution networks. Government-supported healthcare modernization, clinical training, and the digitalization of hospital workflows are also creating favorable conditions for the adoption of image-guided therapeutic platforms.
Europe held a 27.4% share of the image-guided therapy systems market, representing a value of USD 1.47 billion. The region is projected to expand at a CAGR of 6.18%. Its market is supported by established healthcare systems, experienced medical professionals, and sustained adoption of minimally invasive procedures. European hospitals use image-guided platforms across several specialties to enhance accuracy and support real-time treatment decisions. Investments in hospital modernization, hybrid operating environments, and digital healthcare infrastructure continue to encourage adoption. Research collaboration and a strong emphasis on patient safety also influence the development and clinical use of advanced systems.
Germany is a significant European market for image-guided therapy systems because of its advanced hospital infrastructure and strong medical engineering sector. Healthcare facilities are adopting sophisticated imaging and interventional platforms to improve the accuracy of complex procedures. The systems are used in areas such as cardiovascular treatment, oncology, neurosurgery, orthopedics, and interventional radiology. German hospitals place considerable emphasis on clinical quality, patient safety, and evidence-based technology adoption. The presence of research universities, specialist medical centers, and medical device manufacturers supports continuous innovation. Investments in hybrid operating rooms, digital imaging, and workflow integration are further encouraging the use of image-guided therapeutic technologies.
The United Kingdom’s image-guided therapy systems market benefits from established clinical research capabilities and growing interest in minimally invasive treatment. Hospitals are integrating advanced visualization tools with therapeutic procedures to support accurate targeting and real-time clinical guidance. Adoption is developing across oncology, cardiovascular care, neurology, and orthopedic surgery. Public and private healthcare providers are also exploring technologies that can improve treatment efficiency and reduce patient recovery time. Academic medical centers play an important role in evaluating new systems and training specialists. Continued hospital modernization, digital workflow improvements, and collaboration with medical technology companies are supporting the country’s image-guided treatment capabilities.
The Middle East and Africa accounted for 6.8% of the image-guided therapy systems market, with a value of USD 0.36 billion. The region is anticipated to grow at a CAGR of 5.76%. Market development is supported by hospital modernization, expanding specialist care, and increasing interest in advanced diagnostic and therapeutic equipment. Major healthcare centers are adopting image-guided technologies to improve procedural precision and introduce less invasive treatment options. Adoption remains uneven because healthcare infrastructure and access differ across countries. Nevertheless, investments in medical facilities, professional training, and partnerships with international technology providers are strengthening the regional market.
The UAE is emerging as a notable market for image-guided therapy systems due to sustained investment in advanced hospitals and specialized medical services. Healthcare organizations are introducing modern imaging and interventional technologies to improve treatment quality and attract patients seeking complex procedures. Image-guided platforms are increasingly relevant in cardiology, oncology, neurosurgery, orthopedics, and interventional radiology. The country’s focus on digital healthcare and internationally recognized clinical standards supports technology adoption. Partnerships with global medical device manufacturers help hospitals access advanced equipment and professional training. The expansion of specialist centers and medical tourism is also encouraging demand for precise, minimally invasive treatment solutions.
Unlock Regional Insightsto access country-level data, & regional trends.
Customize This Report to Match Your Strategic Objectives
Author's Details
Healthcare Lead
Debashree Bora is a Healthcare Lead with over 7 years of industry experience, specializing in Healthcare IT. She provides comprehensive market insights on digital health, electronic medical records, telehealth, and healthcare analytics. Debashree’s research supports organizations in adopting technology-driven healthcare solutions, improving patient care, and achieving operational efficiency in a rapidly transforming healthcare ecosystem.
We are featured on:
sales@straitsresearch.com